See the DrugPatentWatch profile for keytruda

Yes, patient assistance programs are available for Keytruda. Merck, the pharmaceutical company that manufactures Keytruda, offers the Merck Patient Assistance Program (PAP) to provide Keytruda at no cost to eligible patients who lack sufficient prescription drug coverage and meet specific income requirements [1].

The Merck PAP offers Keytruda free of charge to eligible patients with an annual household income of up to 500% of the federal poverty level (FPL) [1]. Additionally, the program considers other factors such as out-of-pocket expenses, insurance coverage, and the patient's ability to afford their medication [1].

To apply for the Merck PAP, patients must complete and submit an application form along with required documentation, such as proof of income, a copy of their insurance card, and a written doctor's prescription [1]. Once approved, patients can receive Keytruda for up to a year, with the option to reapply annually [1].

Moreover, Merck offers the Merck Access Program, which provides personalized support for patients, caregivers, and healthcare providers throughout the treatment process [1]. This program includes resources such as co-pay assistance, nursing support, and help with insurance-related issues [1].

In summary, patient assistance programs are available for Keytruda through Merck's Patient Assistance Program and the Merck Access Program. These programs offer Keytruda at no cost or reduced co-pays to eligible patients who cannot afford their medication due to insufficient prescription drug coverage or financial hardship [1].

Sources:
[1] DrugPatentWatch.com. (n.d.). Keytruda (pembrolizumab) Patient Assistance Programs. Retrieved from <https://www.drugpatentwatch.com/drugs/keytruda-pembrolizumab/patient-assistance-programs>